3 results
Not approvedWill not start
To determine the prevalence and severity of ASA-related allergic reaction in SM patients.
Approved WMOPending
To determine the prevalence and severity of aspirin-related allergic reactions in SM patients.
Approved WMOCompleted
Primary To test the hypothesis that at least 1 dose of LY2951742 (120 mg or 240 mg/month) is superior to placebo in the prevention of migraine headache in patients with chronic migraineKey Secondary Objectives If LY2951742 (120 or 240 mg/month) is…